Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.
about
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in ratsRole of Natural Stilbenes in the Prevention of CancerAntioxidants in liver healthInteractions between CYP3A4 and Dietary PolyphenolsAn Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of ResveratrolProperties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and HumansResveratrol protects against polychlorinated biphenyl-mediated impairment of glucose homeostasis in adipocytesPterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancerStabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profileUse of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by StilbenesResveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosisThe effect of resveratrol in tracheal tissue of rats exposed to cigarette smoke.Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals.Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging.Sirt1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol.Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.The Benefits of Calorie Restriction and Calorie Restriction Mimetics as Related to the Eye.New delivery systems to improve the bioavailability of resveratrol.Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity.Resveratrol in peanuts.Resveratrol: review on therapeutic potential and recent advances in drug delivery.Distribution of [3H]trans-resveratrol in rat tissues following oral administration.Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.Design and synthesis of compounds that extend yeast replicative lifespan.Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats.Resveratrol: challenges in translation to the clinic--a critical discussion.Effects of resveratrol supplementation on bone growth in young rats and microarchitecture and remodeling in ageing rats.Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells.Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken designInfluence of the gastrointestinal microflora and efflux transporters on the absorption of scutellarin and scutellarein.Resveratrol metabolism in a non-human primate, the grey mouse lemur (Microcebus murinus), using ultra-high-performance liquid chromatography-quadrupole time of flightBioactivation of Phytoestrogens: Intestinal Bacteria and Health.Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.Challenges of translating basic research into therapeutics: resveratrol as an exampleTargeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1.Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cells
P2860
Q24597042-7DB857F6-6D88-43B6-AE68-63DD0F1E25F1Q26769976-776FEA1F-40C1-47FE-8259-BD385E2C8B0CQ26799415-4F117C09-37A6-48B5-B525-985ED02A8089Q26800893-AA47E185-7029-4049-B71E-FDAD77D0E82AQ26800907-2FA77684-5B96-4A26-87AF-3A521A91DFB6Q26801926-1F53AD07-1BE4-44FE-AC6F-658BE2B7EF6CQ28388408-292A0563-91CF-40CF-B462-C07A8F5A6056Q28487488-5455AE8A-63A2-4B66-A594-2180AD0118B6Q28544851-E792028C-DC10-429D-99BB-DA669DDD796FQ28550408-E7A3D3EA-5F4D-4BF0-A969-DC389A1254AEQ28831178-038EE06A-6230-4E05-967D-E03BCA131D92Q33474502-22363D8D-FD13-40B7-91EB-48C9DE5B4064Q33551915-69F9A304-828C-4AD6-8368-3599F79DB5E4Q33624312-3E701BC5-E819-4BA5-96CB-8E4DDFBD7989Q33868687-F78B8F58-BB8D-4D10-83DE-A60C2DDE84DFQ34051374-01ABE486-80CF-4C26-8D31-AC0E1890BB89Q34125724-9206F41B-9E82-4115-A8E2-A84F85DBD91AQ34192059-5EE0C4E5-8FD9-46C5-826B-D5968562577DQ34242787-41D28E83-3485-48E3-9657-590D30729E51Q34257548-46E41E67-C5B6-4656-B0B2-8B740E2C1876Q34392361-43720AD4-3D2B-49A6-AB70-EE6EE4F6A36AQ34420121-B12BFFC0-3839-4988-9CB4-A0FF58949AC1Q34551239-51EFCB28-AFAB-49E7-894B-722114507F30Q34553671-856D3A74-F858-4953-915D-45A195BDDBA8Q34571866-417A2087-323A-4A17-A7CF-50ACDD266D49Q34573125-92EC4BB9-5842-4787-A83B-15F5F9DE9D38Q34585391-0D2DAE4A-6F53-4F71-B8E3-2099DD7800A9Q34673721-F23FD5F8-0930-4DFD-B673-871A7511C038Q34775081-EDD683E8-BDE2-4951-9140-C3D3AEA77D91Q34880559-5D5DC7A3-0426-4244-8B7C-AFFD6358B616Q34997000-BE68868C-80BF-47E5-B77F-3252ADCBFF7EQ35024394-D8C22119-8778-440F-A551-F32BBB9B1B22Q35087954-2533E081-1307-4658-BA7B-97BB18E27FE7Q35129419-0D4ED4FD-F1E6-4BC3-97F5-7599ED6F0191Q35596030-530F5346-2576-4571-B1CE-AD92C062CFA3Q35607205-88C6D75A-1C4A-4ADC-AC38-22482065D83FQ35681280-6B4966CC-C68F-46D2-91EB-E6CC7826D897Q35747309-5FC17BB1-444A-4ED2-A266-67272EA39BADQ35758133-F9CC6D37-FC93-459D-AB90-135494F5C8FEQ35780929-C6426912-9BAE-4E73-AA78-72E6D2710E5A
P2860
Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Metabolism and disposition of ...... idenced by a linked-rat model.
@ast
Metabolism and disposition of ...... idenced by a linked-rat model.
@en
Metabolism and disposition of ...... idenced by a linked-rat model.
@nl
type
label
Metabolism and disposition of ...... idenced by a linked-rat model.
@ast
Metabolism and disposition of ...... idenced by a linked-rat model.
@en
Metabolism and disposition of ...... idenced by a linked-rat model.
@nl
prefLabel
Metabolism and disposition of ...... idenced by a linked-rat model.
@ast
Metabolism and disposition of ...... idenced by a linked-rat model.
@en
Metabolism and disposition of ...... idenced by a linked-rat model.
@nl
P2093
P356
P1476
Metabolism and disposition of ...... idenced by a linked-rat model.
@en
P2093
Ari Gritsas
Jean-Francois Marier
Jean-Pierre Moreau
Murray P Ducharme
Pascal Vachon
P304
P356
10.1124/JPET.102.033340
P407
P577
2002-07-01T00:00:00Z